If a woman aged 65+ has a history of CIN 2/3, how long should she continue cervical cancer screening?

The recommendation for continued cervical cancer screening in women aged 65 and older with a history of cervical intraepithelial neoplasia (CIN) 2/3 is to continue screening for a specified duration based on their risk factors and previous screening history. In this case, a woman who has had CIN 2/3 is considered at higher risk for cervical cancer and should continue screening for a longer period compared to those without such a history.

Continuing screening every 5 years for 20 years ensures that any potential developments can be monitored closely, allowing for timely interventions if necessary. This approach balances the need to manage risk while also considering the potential harms and costs of more frequent screening in an older population.

Although other options suggest different frequencies or durations for screening, they do not align with the guidelines set for women with a history of significant cervical cytological changes like CIN 2/3. The recommendation to continue screening up to 20 years recognizes the ongoing risk this population may face, stressing the importance of vigilant monitoring in ensuring optimal health outcomes.